Clinical Trials
13
Active:0
Completed:8
Trial Phases
4 Phases
Phase 1:2
Phase 2:1
Phase 3:8
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 3
8 (61.5%)Phase 1
2 (15.4%)Phase 4
2 (15.4%)Phase 2
1 (7.7%)Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects
Phase 2
Recruiting
- Conditions
- Pupillary Dilation Effect During Cycloplegic Refraction
- Interventions
- Drug: CTO0303-BDrug: CTO0303-CDrug: CTO0303-A
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-09-24
- Lead Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 156
- Registration Number
- NCT06609525
- Locations
- 🇰🇷
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients
Phase 3
Completed
- Conditions
- Dry EyeDry Eye Syndromes
- Interventions
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 271
- Registration Number
- NCT06427031
- Locations
- 🇰🇷
Taejoon Pharmaceutical Co., Ltd., Seoul, Korea, Republic of
A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy
Phase 3
Completed
- Conditions
- Bowel Preparation
- Interventions
- Drug: CTP0302-BDrug: CTP0302-ADrug: Conventional OST
- First Posted Date
- 2024-03-01
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 161
- Registration Number
- NCT06287606
- Locations
- 🇰🇷
Taejoon Pharmaceutical Co., Ltd., Seoul, Korea, Republic of
A Phase 3 Trial in Bowel Preparation for Colonoscopy
Phase 3
Completed
- Conditions
- Bowel Preparation
- Interventions
- Drug: CTP0301-BDrug: CTP0301-ADrug: Cool prep
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 137
- Registration Number
- NCT05870553
- Locations
- 🇰🇷
Taejoon Pharmaceutical Co., Ltd., Seoul, Korea, Republic of
A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 84
- Registration Number
- NCT05670470
- Locations
- 🇰🇷
Kyung Hee University Hospital at Gangdong, Seoul, Gangdong, Korea, Republic of
- Prev
- 1
- 2
- 3
- Next
News
No news found